Cationic Peptide-Modified Gold Nanostars as Efficient Delivery Platform for RNA Interference Antitumor Therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapy

Background:

• Small interfering RNA (siRNA) interference therapy offers potential for antitumor treatment by silencing target genes in tumor cells.
• Challenges with naked siRNA include degradation in circulation and poor cellular internalization, necessitating advanced delivery systems.
• Efficient delivery vectors are crucial for enhancing the efficacy of siRNA-based cancer therapies.

Purpose of the Study:

• To design and evaluate a novel siRNA delivery nanoplatform for improved tumor targeting and therapeutic efficacy.
• To develop a functional nanoplatform using gold nanostars (GNS-P) decorated with cationic tumor-targeting peptides.

Main Methods:

• Design of gold nanostars (GNS-P) functionalized with cationic tumor-targeting peptides.
• Evaluation of siRNA loading capacity, tumor targeting ability, and cellular internalization of the GNS-P nanoplatform.
• Assessment of biocompatibility and toxicity of the developed nanodelivery system.

Main Results:

• The GNS-P nanoplatform demonstrated a high surface area and positive charge, enabling efficient loading of substantial siRNA amounts.
• The tumor-targeting peptide and nano-size facilitated rapid and precise targeting of tumor regions for effective siRNA delivery.
• The GNS-P nanoplatform exhibited good biocompatibility, low toxicity, and significant tumor accumulation.

Conclusions:

• The developed GNS-P nanoplatform is an efficient and functional siRNA delivery system for cancer therapy.
• This nanoplatform overcomes limitations of naked siRNA, offering enhanced tumor targeting and therapeutic potential.
• GNS-P represents a promising strategy for advancing siRNA-based antitumor treatments.